271. Ankylosing spondylitis Clinical trials / Disease details


Clinical trials : 574 Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04205851
(ClinicalTrials.gov)
November 12, 20194/12/2019Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing SpondylitisAn Ascending Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Gimsilumab in Healthy Subjects and Subjects With Ankylosing SpondylitisInflammation;Rheumatic DiseasesDrug: KIN-1901;Drug: PlaceboKinevant Sciences GmbHNULLCompleted18 Years75 YearsAll36Phase 1Canada